medigraphic.com
ISSN 1817-5996 (Digital)

2019, Número 3

<< Anterior Siguiente >>

Rev Cub de Reu 2019; 21 (3)


Artritis reumatoide, diagnóstico, evolución y tratamiento

Armas RWE, Alarcón MGA, Ocampo DFD, Arteaga CM, Arteaga PPA

Idioma: Español
Referencias bibliográficas: 21
Paginas: 1-9
Archivo PDF: 206.72 Kb.


RESUMEN

La artritis reumatoide es la enfermedad inflamatoria más común en adultos con una alta prevalencia en la población general, invocando para su diagnóstico la presencia de al menos cuatro criterios de los orientados por el Colegio Americano de Reumatología, teniendo un papel protagónico en los últimos años la presencia de anticuerpos anti proteína citrulinada, así como los estudios de imágenes, que ayudan al diagnóstico de la artritis reumatoide temprana en el curso de los dos primeros años de evolución y sus orientaciones terapéuticas adecuadas, aspecto fundamental en la actualidad para evitar las lesiones erosivas irreversibles, que resultan en un marcado compromiso de la calidad de vida de los pacientes que la sufren, elementos que revisamos en este artículo de opinión.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, Juvin R. Prevalence of rheumatoid arthritisin France: 2001. Ann Rheum Dis. 2005;64(10):1427-30

  2. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritisearly: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002;46(2):357-65.

  3. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham III CO, Combe B. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatism. 2010;62(9)9:2569-81.

  4. Osiri M, Sattayasomboon Y. Prevalence and outpatient medical costs ofcomorbid conditions in patients with rheumatoid arthritis. Joint Bone Spine. 2013;80:608.12.

  5. Baker WM. The formation of abnormal synovial cysts in the connection with the joints. St Bartholomew’s Hospital Reports. 1855,21:177-90.

  6. Genovese GR, Jayson MI, Dixon AS. Protective value of synovial cysts in rheumatoid knees. Ann Rheum Dis. 1972;31:179-82.

  7. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002;46:357-65.

  8. Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, Uffmann M, Smolen JS. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford). 2007;46:342-9.

  9. Halvorsen EH, Haavardsholm EA, Pollmann S, Boonen A, van der Heijde D, Kvien TK, Molberg O. Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Ann Rheum Dis. 2009;68:249-52.

  10. McInnes I, Schett G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat Immunol. 2007;7:429-42.

  11. Aletaha D, Smolen J, Ward MM: Measuring function in rheumatoid arthritis: identifying reversible and irreversible components. Arthritis Rheum. 2006;54:2784-92.

  12. Kekow J, Moots RJ, Emery P, Durez P, Koenig A, Singh A, Pedersen R, Robertson D, Freundlich B, Sato R: Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. Ann Rheum Dis. 2010;69:222-5.

  13. Tiderius CJ, Sandin J, Svensson J, Dahlberg LE, Jacobsson L. Knee cartilage quality assessed with GEMRIC in rheumatoid arthritis patients before and after treatment with a TNF inhibitor. Acta Radiol. 2010;51:1034-7.

  14. Moller Døhn U, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, Moller JM, Ostergaard M: Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1-year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure. Ann Rheum Dis. 2009;68:1585-90.

  15. Salimi C, O’Neill J, Khalidi N, Harish S: Role of ultrasound in the assessment of small-joint synovitis. Can Assoc Radiol J. 2009;60:69-70.

  16. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL: TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000;106:1481-8.

  17. Møller Døhn U, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, Moller JM, Ostergaard M. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1-year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure. Ann Rheum Dis. 2009;68:1585-90.

  18. Finzel S, Englbrecht M, Engelke K, Stach C, Schett G. A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis. 2011;70:122-7.

  19. Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis. 2003;62:68-70.

  20. Abu-Shakra M, Gladman DD, Thorne JC, Long J, Gough J, Farewell VT: Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome. J Rheumatol, 1995;22:241-5.

  21. Chandran V, Schentag CT, Gladman DD: Reappraisal of the eff ectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort. J Rheumatol. 2008;35:469-71.




2020     |     www.medigraphic.com